Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Methylergonovine Maleate Injection, USP 0.2mg/mL. This product is an AP rated generic to Methergin®, a product owned by Edison Therapeutics, LLC. and is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum hemorrhage. Breckenridge is launching this product in conjunction with the ANDA holder, Ergoject, LLC.